Study of EVO756 in Adults With Migraine
Evommune, Inc. · NCT07616128
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–64 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 2
- Target enrollment
- 330
- US sites recruiting
- 33
- Study start
- July 29, 2026
- Record last updated
- October 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Being studied: EVO756, Dose 1; EVO756, Dose 2; Placebo
Conditions: Migraine
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Key Inclusion Criteria
- Adults aged 18 to \<65 years
- Migraine with or without aura, per ICHD-3 criteria
- History of failure with prior preventive migraine treatments
- Not currently using migraine preventive therapy
Key Exclusion Criteria
- Difficulty distinguishing migraine from other headache types or presence of other primary headache disorders
- Use of certain medications
- Any clinically significant medical, psychiatric, neurological, cardiovascular, or laboratory abnormalities
Recruiting US locations
Trialsphere Corp
Chandler, AZ 85286
Site contact: EVO756-MIG001 Research Site · 6232679314 · ClinicalResearch@TrialSphereAZ.com
Buena Park Research Center
Buena Park, CA 90620
Site contact: EVO756-MIG001 Research Site · 714-678-1700 · info@buenaparkresearch.com
Neuro Pain Research Center
Fresno, CA 93710
Site contact: EVO756-MIG001 Research Site · 5594379700 · lflores@neuropain.com
CA Medical Clinic for Headache
Los Angeles, CA 90067
Site contact: EVO756-MIG001 Research Site · (323)879-9999 · jlatorre@clinicalri.net
Diablo Clinical Research dba Flourish Research
Walnut Creek, CA 94598
Site contact: EVO756-MIG001 Research Site · 9259307267 · kabdullah@flourishresearch.com
Hasbani Neurology
New Haven, CT 06511
Site contact: EVO756-MIG001 Research Site · 203-562-8071 · jude@neinh.com
New England Institute for Neurology and Headache
Stamford, CT 06905
Site contact: EVO756-MIG001 Research Site · 203-914-1903 · annelise@neinh.com
Clinical Neuroscience Solutions, Inc.
Jacksonville, FL 32256
Site contact: EVO756-MIG001 Research Site · 904-281-5757 · bsagil@cnshealthcare.com
Apple Medical Research Group, Inc
Miami, FL 331216
Site contact: EVO756-MIG001 Research Site · 3056678434 · info@applemedresearch.org
Blessed Healthcase & Research
Miami, FL 33173
Site contact: EVO756-MIG001 Research Site · 786-491-9998 · droman@blessedclinicaltrials.com
Florida Research Center, Inc.
Miami, FL 33174
Site contact: EVO756-MIG001 Research Site · 7865369009 · regulatory@floridarc.net
Clinical Neuroscience Solutions, Inc.
Orlando, FL 32819
Site contact: (407) 425-5100 · orlinfo@cnshealthcare.com
Vantage Clinical Trials
Tampa, FL 33614
Site contact: EVO756-MIG001 Research Site · 8135495265 · ysanchez@vantagetrials.com
Premiere Research Institute at Palm Beach Neurology
West Palm Beach, FL 33407
Site contact: EVO756-MIG001 Research Site · 5618519400 · e.amodie@palmbeachneurology.com
Clinical Integrative Research Center of Atlanta
Atlanta, GA 30328
Site contact: EVO756-MIG001 Research Site · (678) 705-7341 · info@pandaneuro.com
Accel Research Site-Decatur-Alcanza
Decatur, GA 30030
Site contact: EVO756-MIG001 Research Site · 404-475-0552 · benoit.tete@accelclinical.com
Neurology Center of New England P.C.
Foxborough, MA 02035
Site contact: EVO756-MIG001 Research Site · 781-551-5812 · info@neurocenterne.com
Mass Institute of Clinical Research
Westborough, MA 01581
Site contact: EVO756-MIG001 Research Site · 9786843011 · research@micr.life
Michigan Headache and Neurological Institute
Ann Arbor, MI 48104
Site contact: EVO756-MIG001 Research Site · 734-677-6000 · research@mhni.com
Quest Research Institute-Alcanza
Farmington Hills, MI 48334
Site contact: EVO756-MIG001 Research Site · 2489578940 · Denise.Morgott@questri.com
Bio Behavoural health
Toms River, NJ 08755
Site contact: 732-244-2299 · jryan@bbhnj.com
Clinosis - Dent Neurologic Instite
Amherst, NY 14226
Site contact: EVO756-MIG001 Research Site · 716-250-2017 · abryan@dentinstitute.com
Asheville Neurology Specialists, Pa
Asheville, NC 28806
Site contact: EVO756-MIG001 Research Site · (828) 210-9306 · amberc@ashneuro.com
Eximia Research NC
Raleigh, NC 27607
Site contact: EVO756-MIG001 Research Site · (919) 800-5154 · achambers@eximiaresearch.com
NeuroScience Research Center
Canton, OH 44718
Site contact: EVO756-MIG001 Research Site · 330-244-2542 · nrc@neurocarecenter.com
Clinical Trials of South Carolina
Charleston, SC 29406
Site contact: EVO756-MIG001 Research Site · 843-725-5067 · Info@clinicaltrialssc.com
Campbell Clinical Research
Franklin, TN 37067
Site contact: EVO756-MIG001 Research Site · 615-550-1800 · sdawes@ccrsite.com
FutureSearch Trials of Neurology
Austin, TX 78731
Site contact: EVO756-MIG001 Research Site · (512) 380-9925 · ATXClinic@fstrials.com
FutureSearch Trials of Dallas
Dallas, TX 75251
Site contact: EVO756-MIG001 Research Site · 214-361-7700 · dallasleads@fstrials.com
SFF Medical Research Group LLC
Houston, TX 77018
Site contact: EVO756-MIG001 Research Site · (832) 533-8872 · nichole.baio@evommune.com
Mercury Clinical Research Inc. - Houston Neurology Associates
Houston, TX 77478
Site contact: EVO756-MIG001 Research Site · 7137775343 · jmmendez@mercurycr.us.com
MedStar Health: Headache Center at McLean
McLean, VA 22101
Site contact: EVO756-MIG001 Research Site · 202-295-0545 · helen.girma@medstar.net
Vaught Neurological Services
Crab Orchard, WV 25827
Site contact: EVO756-MIG001 Research Site · 304-252-4222 · research@vaughtneurology.com
Study contacts (from the official record)
- Nichole Baio · (650) 319-4553 · nichole.baio@evommune.com
Similar studies in Arizona
All neurology studies in Arizona →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Tucson, AZ + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
[18F]PI-2620 Phase 3 Histopathological Study
Lantheus Biosciences Ltd.
- Location
- Phoenix, AZ + 16 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Sun City, AZ + 24 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- Phoenix, AZ + 21 other US sites
- Eligibility basics
- Ages 18–75